Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SHIRE (LSS: SHP)
21.55 GBP  +0.20 (+0.94%)
Streaming Delayed Price  /  Updated: 11:35 AM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News
All news about SHIRE
 
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
May 20, 2013
Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases Read More
from PR Newswire
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
May 17, 2013
from PR Newswire
Shire Wins Patent Trial Against Watson Concerning LIALDA®
May 09, 2013
from PR Newswire
Acceleron and Shire Conclude Collaboration on ACE-031
May 02, 2013
from Business Wire News Releases
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
May 02, 2013
from PR Newswire
Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD
May 01, 2013
Becomes the first stimulant medication approved for maintenance treatment in patients ages 6 and above with ADHD Read More
from PR Newswire
Shire Settles All Pending Litigation with Actavis and Watson Concerning INTUNIV®
April 25, 2013
from PR Newswire
Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
April 09, 2013
New findings reveal the substantial burden of rare diseases due to lack of resources, financial challenges and emotional unrest Read More
from PR Newswire
Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
March 25, 2013
Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease Read More
from PR Newswire
Shire Acquires Premacure AB
March 12, 2013
Deal Enhances Shire's Late-Stage Pipeline with the Acquisition of a Phase II Protein Replacement Therapy Being Investigated for the Prevention of Retinopathy of Prematurity Read More
from PR Newswire
Shire Supports Rare Disease Day 2013
February 28, 2013
from PR Newswire
Shire's VPRIV® Wins First Ever "Novel Treatment Award" From Lysosomal Disease Network at Their 9th WORLD Symposium
February 19, 2013
from PR Newswire
Paulson's Paulson & Co. Shows New Stakes in Aetna (AET), Alpha Natural (ANR), Mead Johnson (MJN)
February 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8102768 for the full story. Read More
from StreetInsider.com News Articles
Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013
February 14, 2013
from PR Newswire
Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
February 13, 2013
The month-long "The Diabetic You" mobile bus tour will visit five Arizona and California communities Read More
from PR Newswire
Shire and Impax Settle Litigation Concerning Supply of Adderall XR Authorized Generic
February 08, 2013
from PR Newswire
Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
February 08, 2013
from PR Newswire
Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
February 06, 2013
from PR Newswire
Shire Reaches Agreement in Principle With U.S. Government
February 01, 2013
from PR Newswire
Shire - Guidance Update
January 08, 2013
from PR Newswire
Shire Acquires Lotus Tissue Repair, Inc.
January 08, 2013
HGT Pipeline Enhanced with Protein Replacement Therapy Being Investigated for the Treatment of Dystrophic Epidermolysis Bullosa Read More
from PR Newswire
Positive Response from European Regulatory Procedure Supports Approval of Elvanse® (lisdexamfetamine dimesylate) for ADHD
December 18, 2012
from PR Newswire
Shire and Boston Children's Hospital Enter Into Broad Research Collaboration
November 20, 2012
from PR Newswire
Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
November 19, 2012
Impact Report to assess holistic needs of rare disease patient and medical communities Read More
from PR Newswire
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
November 15, 2012
from PR Newswire
Angus Russell to Retire in 2013: Dr Flemming Ornskov to Succeed as Chief Executive
October 25, 2012
from PR Newswire
Shire on Track for Double Digit Full Year Earnings Growth
October 25, 2012
from PR Newswire
Shire Enters into Novel Research Collaboration with Italian-based Telethon's Institute of Genetics and Medicine for Rare Diseases
October 24, 2012
from PR Newswire
AMRI Announces Five-Year Extension of API Supply Agreement With Shire
October 18, 2012
from PR Newswire
Sangamo BioSciences Announces First Presentation of Data from ZFP Therapeutic® for Huntington's Disease at 2012 Annual Meeting of Society for Neuroscience
October 17, 2012
Novel ZFP Therapeutic Approach Selectively Represses Only the Disease-Causing Gene Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here